Russian Federation: Mifepristone EC pills less accessible

March 2025. Emergency contraceptive (EC) pills with a low dose of mifepristone (10 to 25 mg), have been available in a few countries for many years, including Armenia, Russia, China, Moldova, Ukraine and Vietnam.

In 2023, however, the Ministry of Health of the Russian Federation approved a list of drugs and active ingredients that are to be “subject to quantity control”. Mifepristone was included in this list, which did not specify dosages nor indications. This measure, which came into effect in September 2024, makes the use of mifepristone (at a low dose for emergency contraception, and at a higher dose for medical abortion) far more restricted and its prescription more bureaucratically burdened. On the other hand, the Ministry of Health made LNG EC pills available without a prescription in early 2024 (read more here).  

Learn more:

  • The Ministry of health issued an order limiting the circulation of drugs for medical termination of pregnancy and emergency contraception“, article published in October 2023, by the independent journal Meduza: available in English and Russian.

Similar Posts

  • Russia: Restrictions to online EC information and care.

    January 2026. According to the independent outlet Meduza, “since September 2025, Russia’s federal censorship agency, Roskomnadzor, has blocked websites accused of “promoting refusal of childbirth””, including pages that provided information on and access to emergency contraception (EC) pills. The Emergency Contraception Storage Fund, a grassroots initiative to secure access to EC pills, was forced to…

  • TED-Ed releases new lesson explaining how the “morning-after pill” prevents pregnancy

    March 2026. A new animated lesson from TED-Ed explores the science behind emergency contraception and answers a common question: how does the morning-after pill actually work? In “How does the morning-after pill prevent pregnancy?”, physician and researcher Alison Edelman explains the biological mechanisms behind emergency contraceptive pills and addresses widespread misconceptions about their function. Using…

  • Argentina: New data on EC use and access

    November 2024. The Study Lucía: Uses and preferences of contraceptive methods in women aged 15 to 49 years in Argentina, was recently published. This quantitative and qualitative research has consulted 2,000 women and people identifyin as LGTB from all over the nation. The study findings, published in September 2024, include valuable information about access to…

  • Portugal: new EC practical guide for pharmacists

    In February 2015, the Portuguese Society of Contraception launched a practical EC guide for pharmacists. After Portugal decided to follow the European Union Commission recommendation to make UPA EC accessible directly from pharmacies without prescription, UPA EC is expected to be available directly from pharmacists in the country in the next few months. The Portuguese…

  • Romania: New EC counseling tool

    In Romania, MagnaPharm has translated and adapted the EC Wheel to help strengthen pharmacists’ knowledge on EC methods and counseling. The EC Wheel was developed in 2016 by ECEC with financial and technical support from the European Society of Contraception and Reproductive Healthcare (ESC). This tool summarizes the UK Faculty of SRH and WHO’s recommendations…

  • German Health Committee Rejects Request for OTC LNG EC

    On May 15th, the Health Committee of the Bundestag  (German parliament) resolved not to remove the prescription status of LNG EC. The coalition currently in office (CDU and FDP),  turned down the request by the SPD and Die LINKE parties to change LNG to prescription-free status. The political parties that requested the change of status claim…